Analyst Mark Massaro works at BTIG and is focused on the Healthcare sector with 610 price targets and ratings documented since 2012 spanning on 33 stocks. Analyst's average stock valuation to be materialised ratio is 49.05% with an average time for price targets to be met of 166.12 days.
Most recent stock forecast was given on DMTK, at 08-Nov-2022.
Mark Massaro best performing recommendations are on GHDX.
The best stock recommendation documented was for GHDX at 11/7/2018. The price target of $82 was fulfilled within 2 days with a profit of $8.18 (9.07%) receiving and performance score of 45.35.
Average potential price target upside